Revolution Medicines, Inc. (RVMD) Covered Calls

You can sell covered calls on Revolution Medicines, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RVMD (prices last updated Fri 4:16 PM ET):

Revolution Medicines, Inc. (RVMD) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
55.13 -2.24 53.57 56.83 1.8M - 10
Covered Calls For Revolution Medicines, Inc. (RVMD)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 55 4.70 52.13 5.5% 55.8%
Jan 17 55 6.10 50.73 8.4% 47.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit targets primarily within the RAS and mTOR signaling pathways. The company's principal product candidate is RMC-4630, an inhibitor of SHP2, which is in Phase 1b/2 study for the treatment of RAS-dependent tumors. Its products in preclinical stage include mutant RAS proteins; SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a mTORC1 inhibitor. Revolution Medicines, Inc. has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors. The company was founded in 2014 and is headquartered in Redwood City, California.